Benvenue Medical Secures $64 Million Financing
June 18, 2014Benvenue Medical, Inc. announced completion of a $64 million Series E round of financing. The proceeds will go towards building their commercial presence, manufacturing, and to support overall corporate growth.
More »
Regado Biosciences Appoints Pharmaceutical Business Leader Drew Fromkin to Board of Directors
June 18, 2014Regado Biosciences, Inc. announced the appointment of business leader, Drew Fromkin, to the company’s Board of Directors. He most recently served as President and CEO of Clinical Data, Inc., a global life sciences company.
More »
Bio-Techne Announces Agreement to Acquire ProteinSimple
June 17, 2014Bio-Techne announced their agreement to acquire ProteinSimple for $300 million. ProteinSimple develops and commercializes proprietary systems and consumables for protein analysis in efforts to reveal the true nature of proteins.
More »